YHB Investment Advisors Inc. Sells 1,009 Shares of CME Group Inc (NASDAQ:CME)

YHB Investment Advisors Inc. trimmed its stake in CME Group Inc (NASDAQ:CME) by 3.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 29,818 shares of the financial services provider’s stock after selling 1,009 shares during the period. YHB Investment Advisors Inc.’s holdings in CME Group were worth $5,788,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Dubuque Bank & Trust Co. raised its position in shares of CME Group by 83.1% in the 1st quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 69 shares in the last quarter. Truvestments Capital LLC purchased a new position in CME Group during the 1st quarter worth $32,000. Close Asset Management Ltd purchased a new position in CME Group during the 1st quarter worth $34,000. Permanens Capital L.P. purchased a new position in CME Group during the 1st quarter worth $41,000. Finally, Berman Capital Advisors LLC grew its stake in CME Group by 23.9% during the 1st quarter. Berman Capital Advisors LLC now owns 342 shares of the financial services provider’s stock worth $56,000 after buying an additional 66 shares during the last quarter. 84.68% of the stock is owned by hedge funds and other institutional investors.

In other news, CFO John W. Pietrowicz sold 2,500 shares of the company’s stock in a transaction dated Tuesday, July 9th. The stock was sold at an average price of $201.30, for a total value of $503,250.00. Following the sale, the chief financial officer now owns 32,854 shares in the company, valued at $6,613,510.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Timothy S. Bitsberger sold 700 shares of the company’s stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $194.35, for a total value of $136,045.00. Following the completion of the sale, the director now owns 9,421 shares in the company, valued at approximately $1,830,971.35. The disclosure for this sale can be found here. In the last quarter, insiders have sold 48,873 shares of company stock worth $9,467,749. Company insiders own 1.20% of the company’s stock.

CME Group stock traded down $2.88 during trading hours on Wednesday, hitting $194.43. 59,069 shares of the stock traded hands, compared to its average volume of 1,019,607. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.04 and a quick ratio of 1.04. The firm’s 50 day moving average price is $200.52. The firm has a market capitalization of $71.79 billion, a PE ratio of 28.48, a price-to-earnings-growth ratio of 4.43 and a beta of 0.23. CME Group Inc has a 1 year low of $158.35 and a 1 year high of $207.84.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.75 by $0.01. The business had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a return on equity of 9.29% and a net margin of 42.47%. The company’s quarterly revenue was up 20.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.74 EPS. Sell-side analysts expect that CME Group Inc will post 6.75 earnings per share for the current year.

Several brokerages recently weighed in on CME. ValuEngine downgraded Valero Energy from a “hold” rating to a “sell” rating in a research note on Wednesday, May 8th. Bank of America set a $180.00 target price on CME Group and gave the stock a “hold” rating in a research note on Tuesday, April 9th. Citigroup downgraded BCE from a “buy” rating to a “neutral” rating in a research note on Thursday, May 2nd. Rosenblatt Securities downgraded CME Group from a “neutral” rating to a “sell” rating in a research note on Thursday, April 18th. Finally, Barclays restated a “sell” rating on shares of Royal Bank of Canada in a research note on Thursday, May 23rd. Three analysts have rated the stock with a sell rating, five have given a hold rating and eight have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $192.14.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: Net Margin – Understanding the Different Kinds of Profit

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.